Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

Abstract Background Rituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is broadly accepted as standard for the treatment of diffuse large B-cell lymphoma (DLBCL). Nevertheless, there is sparsely data concerning the management of elderly p...

Full description

Bibliographic Details
Main Authors: Roland Christian Schelker, Wolfgang Herr, Albrecht Reichle, Martin Vogelhuber
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Diffuse large B-cell lymphoma
Rituximab
Trofosfamide
Elderly patients
Online Access:http://link.springer.com/article/10.1186/s12885-018-4885-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4885-5

Similar Items